[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001248751A1 - Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity - Google Patents

Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity

Info

Publication number
AU2001248751A1
AU2001248751A1 AU2001248751A AU4875101A AU2001248751A1 AU 2001248751 A1 AU2001248751 A1 AU 2001248751A1 AU 2001248751 A AU2001248751 A AU 2001248751A AU 4875101 A AU4875101 A AU 4875101A AU 2001248751 A1 AU2001248751 A1 AU 2001248751A1
Authority
AU
Australia
Prior art keywords
disintegrating
oral cavity
preparations
compositions
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248751A
Inventor
Kazutoshi Aizawa
Kiyofumi Ishikawa
Makoto Narushima
Hiroyasu Shimoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of AU2001248751A1 publication Critical patent/AU2001248751A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001248751A 2000-04-12 2001-04-11 Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity Abandoned AU2001248751A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-110396 2000-04-12
JP2000110396 2000-04-12
PCT/JP2001/003114 WO2001076565A1 (en) 2000-04-12 2001-04-11 Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity

Publications (1)

Publication Number Publication Date
AU2001248751A1 true AU2001248751A1 (en) 2001-10-23

Family

ID=18622916

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248751A Abandoned AU2001248751A1 (en) 2000-04-12 2001-04-11 Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity

Country Status (3)

Country Link
JP (2) JP4802436B2 (en)
AU (1) AU2001248751A1 (en)
WO (1) WO2001076565A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001248751A1 (en) * 2000-04-12 2001-10-23 Banyu Pharmaceutical Co. Ltd. Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity
JP4551627B2 (en) * 2003-02-28 2010-09-29 東和薬品株式会社 Method for producing orally disintegrating tablets
JP5584509B2 (en) * 2003-02-28 2014-09-03 東和薬品株式会社 Orally disintegrating tablets
JP5062871B2 (en) * 2003-05-13 2012-10-31 東和薬品株式会社 Orally disintegrating tablets with reduced bitterness
JP5062872B2 (en) * 2003-08-13 2012-10-31 東和薬品株式会社 Orally disintegrating tablets with reduced unpleasant taste
JP2005306770A (en) * 2004-04-21 2005-11-04 Toa Eiyo Ltd Intraoral quick collapse type preparation and method for producing the same
CN101180046B (en) 2005-05-18 2011-12-28 大日本住友制药株式会社 Stable tablet containing droxidopa
US8778392B2 (en) * 2007-03-13 2014-07-15 Dainippon Sumitomo Pharma Co., Ltd. Oral disintegrating tablet
ES2381056T3 (en) 2007-04-26 2012-05-22 Toray Industries, Inc. Stable solid preparation containing a 4,5-epoxymorphinan derivative
US9314454B2 (en) 2007-12-28 2016-04-19 Sawai Pharmaceutical Co., Ltd. Oral cavity disintegrating tablet and method of producing the same
EP2262487A2 (en) * 2008-02-29 2010-12-22 Otsuka Pharmaceutical Co., Ltd. An orally disintegrating tablet of cilostazol
ES2400774T3 (en) * 2008-06-13 2013-04-12 Dainippon Sumitomo Pharma Co., Ltd. Tablet that disintegrates rapidly in the oral cavity and method for its production
EP2397161B1 (en) * 2009-02-12 2019-09-25 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same
WO2011121823A1 (en) * 2010-03-29 2011-10-06 アステラス製薬株式会社 Particulate pharmaceutical composition for oral administration
WO2011121824A1 (en) * 2010-03-29 2011-10-06 アステラス製薬株式会社 Orally disintegrating tablet
PE20140255A1 (en) 2011-01-17 2014-03-11 Takeda Pharmaceutical DISPERSIBLE TABLET IN ORAL FORM
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
UY34847A (en) 2012-06-05 2014-01-31 Takeda Pharmaceutical SOLID PREPARATION
JP5713421B1 (en) 2013-07-19 2015-05-07 株式会社三和化学研究所 Orally disintegrating tablets
GB201400034D0 (en) * 2014-01-02 2014-02-19 Astrazeneca Ab Pharmaceutical Compositions comprising AZD9291
JP6002870B1 (en) * 2015-10-16 2016-10-05 持田製薬株式会社 Orally disintegrating tablets containing low dose drugs
WO2017115764A1 (en) * 2015-12-28 2017-07-06 日本新薬株式会社 Compression-molded preparation
JP6858575B2 (en) * 2016-01-29 2021-04-14 沢井製薬株式会社 Orally disintegrating tablets containing nalfurafine
WO2019146642A1 (en) * 2018-01-24 2019-08-01 大原薬品工業株式会社 METHOD FOR IMPROVING CHEMICAL STABILITY OF γ-AMINOBUTYRIC ACID DERIVATIVE- CONTAINING TABLET

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2523384B2 (en) * 1990-02-02 1996-08-07 エスエス製薬株式会社 Effervescent pharmaceutical composition
JP2919771B2 (en) * 1995-04-17 1999-07-19 佐藤製薬株式会社 Method for producing fast-dissolving tablet and fast-dissolving tablet produced by the method
JPH09194381A (en) * 1996-01-17 1997-07-29 Kowa Co Chewable tablet containing calcium salt
ATE400299T1 (en) * 1996-07-12 2008-07-15 Daiichi Seiyaku Co RAPIDLY DEGRADING, PRESSURE-FORMED MATERIALS AND THE PROCESS FOR THEIR PRODUCTION
JPH10182436A (en) * 1996-10-31 1998-07-07 Takeda Chem Ind Ltd Solid medicinal preparation
JPH10287555A (en) * 1997-04-14 1998-10-27 Kowa Co Chewable tablet
JPH10298062A (en) * 1997-04-24 1998-11-10 Pfizer Pharmaceut Co Ltd Rapidly dissolving type tablet in oral cavity
TWI257311B (en) * 1998-07-28 2006-07-01 Takeda Chemical Industries Ltd Rapidly disintegrable solid preparation
JP4504467B2 (en) * 1998-07-30 2010-07-14 佐藤製薬株式会社 Orally disintegrating tablets
JP2000178182A (en) * 1998-12-17 2000-06-27 Lion Corp Disintegrable composition
AU2001248751A1 (en) * 2000-04-12 2001-10-23 Banyu Pharmaceutical Co. Ltd. Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity

Also Published As

Publication number Publication date
WO2001076565A1 (en) 2001-10-18
JP2011225588A (en) 2011-11-10
JP4802436B2 (en) 2011-10-26
JPWO2001076565A1 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
AU2001248751A1 (en) Compositions disintegrating in oral cavity and preparations disintegrating in oral cavity
AU2001268743A1 (en) Oral care compositions comprising chlorite and methods
AU2002230217A1 (en) Tablets quickly disintegrated in oral cavity
AU2001286924A1 (en) Tools and methods for creating cavities in bone
AU2001294250A1 (en) Medicinal compositions quickly disintegrating in the oral cavity and process forproducing the same
AU2778801A (en) Antisense compositions and methods
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU7645701A (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
AU2001233739A1 (en) Use of natural substances in the production of cosmetic preparations
AU2001238363A1 (en) Compositions for preventing cellulite in mammalian skin
AU4967601A (en) Stable and efficacious soft solid product
AU2002358594A1 (en) Emollients and cosmetic compositions
AU7924200A (en) Tooth whitening products and procedures
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2002306461A1 (en) In vivo delivery methods and compositions
AU2738000A (en) Oral hygiene preparations; associated methods and kit
AU2002211690A1 (en) Altered hox and wnt7a expression in human lung cancer
AU2001261317A1 (en) Immunostimulant compositions and associated methods
AU4876701A (en) Peptide derivatives and medicinal compositions
AU2001241187A1 (en) Sustained release oral preparations
AU2001258714A1 (en) Herbal composition useful for treatment or oral cavity and method for its local delivery thereof
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2001290072A1 (en) Improvements in and relating to shuttering
AU2002226986A1 (en) In vivo delivery methods and compositions
AU2001259564A1 (en) Pharmaceutical compositions and methods for use